Find out about the latest treatment and drug pipeline developments
Managed care organizations may be the next target of value-based reimbursements, with bonus payments tied to the health of their company—and its members.
High drug prices continue to plague payers, but various contributing factors intensify the problem.
Results from Managed Healthcare Executive’s annual State of the Industry Survey reveal which issues will hit managed healthcare hardest in 2017.
CMS is adding, dropping, and expanding payment rules
Plans and PBMs are finding new ways to rein in pharmacy costs.
Does your analytics team have what it takes? Experts share their top recommendations.
Experts share how Trump could change Obamacare coverage, accessibility, affordability, Medicare/Medicaid, price transparency, and more.
Here’s how you can recognize changes in the oncology pipeline and maximize value related to cancer care.
Here are some of the latest precision medicine approaches being used by managed care organizations, health systems and academic medical centers across the U.S.